Study Shows Promise of New Treatment Approach in 3D Brain ‘Organoid’ Model
Our cells’ survival depends on their ability to take in the nutrients and other substances that they require. Unfortunately, this capacity is a double-edged sword, as cells can bring in both valuable resources and ticking time bombs. However, IRP researchers recently identified an existing drug that may be able to combat Parkinson’s disease by reducing cells’ penchant for snatching up the toxic proteins involved in Parkinson’s disease.
IRP Researchers are Developing Vaccines Targeting the ‘Achilles Heel’ of a Wiley Infectious Threat
In the 40 years since HIV, the virus behind AIDS, was first definitively identified, treatments have changed the disease from a sure death to a long-term chronic illness. Yet, as we passed the 36th annual commemoration of World AIDS Day on December 1, it remains a dangerous health threat. Consequently, many researchers are attempting to develop vaccines to prevent or treat HIV, including IRP senior investigator Barbara K. Felber, Ph.D. Dr. Felber has been pursuing an effective vaccine since the discovery of HIV in the early 1980s using a unique approach that is not only making headway toward that important goal, but also offering insights into other infectious diseases, as well as cancer immunotherapy.
IRP Program Boosts Careers of Promising Physician-Scientists
Many scientists have a seemingly single-minded focus on their research, but there are considerable benefits to having one foot in the lab and the other in the clinic. Working with patients gives researchers a daily reminder of the people they are working so hard to help and allows them to investigate the effects of promising but still experimental treatments in willing volunteers. That’s one of the main reasons why the IRP’s Lasker Clinical Research Scholars Program is designed to accelerate the careers of promising early-career physician-scientists.
This year, four NIH researchers began receiving support from the Lasker program, allowing them to dramatically expand their cutting-edge research. From investigating the roots of muscle-weakening genetic conditions to probing the mysteries of rare, hormone-producing tumors, these individuals will use the leg up provided by the Lasker Program to make new discoveries that could one day improve their patients’ lives. Read on to learn more about the exciting research the latest crop of Lasker Scholars is pursuing.
New IRP Research Hints at Possible Culprits Behind Long-COVID
Nearly five years after COVID-19 first raged across the United States, most people have some immunity to the disease through vaccination or a prior infection. However, COVID not only remains a continued threat to vulnerable individuals, but also has saddled some patients with lasting symptoms. New IRP research provides a starting point for better understanding that ‘long-COVID’ phenomenon by identifying an array of substances in the blood whose levels are abnormal months after people catch the illness.
IRP Research is Exploring the Role of Immune Cells in Dementia
If you visit a lab at NIH’s Center for Alzheimer’s and Related Dementias (CARD), you may find yourself surrounded by several robots hard at work nurturing the hundreds of sets of genetically modified stem cells that CARD scientists use to study the illnesses that give CARD its name. Many of these cells will be coaxed to mature into the neurons that power our movements, thoughts, and memories — but not all of them. Neurons have long received the lion share of dementia researchers’ attention, understandable seeing as the visible symptoms of Alzheimer’s disease are closely linked to a build-up of proteins — amyloid-beta and misfolded tau — that damage neurons. However, neurons aren’t the only brain cells involved in dementia.
IRP’s Oral Health Experts Explore Why It’s Not Always About Brushing and Flossing
When you dig into that bowl of candy this Halloween, you may want to keep in mind that those sweets are not only fueling your sweet tooth, but also an army of creepy crawlies living in your mouth, busily forming a sticky film of plaque and attacking your gums.
As Dental Hygiene Month comes to a close this October, we spoke with IRP Clinical Research Specialist Laurie Brenchley, R.D.H., a dental hygienist and clinical study coordinator in the laboratory of IRP senior investigator Niki Moutsopoulos, D.D.S., Ph.D. Together, Brenchley and Dr. Moutsopoulos are studying the link between oral health and the immune system, with a specific focus on cases in which genetic factors increase susceptibility to severe gum disease, more formally known as periodontitis.
No single event captures the incredible breadth of research going on in the IRP as effectively as the annual NIH Research Festival. In fact, the event is so jam-packed that it typically stretches over multiple days, running this year from September 23-25. The first day of the 2024 Research Festival kicked off with a poster session where scientists from all across NIH showcased the cutting-edge science they have been working on, demonstrating research on subjects like how cooking affects the brain, vaping’s impact on lung health, 3D models for studying pregnancy complications, and much more. Read on to dive deeper into a few of the more than 400 research projects presented at this celebration of IRP science.
NIH Director Monica M. Bertagnolli, M.D., offered the following tribute to Dr. John I. Gallin, M.D., upon hearing of his passing on Thursday, October 10, 2024.
It is with a heavy heart that I share that John I. Gallin, M.D., the 10th and longest-serving director of the NIH Clinical Center, died at his home today of multiple myeloma at the age of 81 with his wife Elaine Gallin, Ph.D., by his side.
John’s illustrious career at NIH spanned more than 50 years, but he will be most remembered for leading NIH’s research hospital for 23 years from 1994-2017. He often said that his time at the NIH Clinical Center, which he referred to as the “House of Hope,” was his most special because of the hospital’s partnership with patients to improve health through clinical research. He developed the hospital’s research portfolio, created the Patient Advisory Group, established the Department of Bioethics, and was instrumental in the creation of the Edmond J. Safra Family Lodge for adult patients and their families, a complement to The Children’s Inn. He also led efforts to build the addition to the hospital, the Mark O. Hatfield Clinical Research Center, which opened to patients in 2005. He started the Bench-to-Bedside Awards to integrate the work of basic and clinical investigators. His years of work led to the NIH Clinical Center receiving the 2011 Lasker-Bloomberg Public Service Award.
IRP Mouse Study Suggests Intervention Might Reduce Health Problems Associated with C-Section Births
Every kid’s first gift from their mom is half of her DNA, but nearly a third of children born nowadays miss out on a bonus present. That’s because babies born via vaginal delivery are exposed to the microorganisms that live in the vagina, but infants born via Cesarian section are not. A new IRP mouse study suggests that an intervention designed to make up for this missed opportunity could reduce the risk of certain health problems that are more common in babies born via C-section.
More than half of Americans are registered organ donors, signed up to gift organs like kidneys and livers to patients in need of a transplant when they die. However, far fewer people have signed up to donate their brains to biomedical research upon their deaths. At NIH, the Human Brain Collection Core (HBCC) acts as a steadfast steward of this precious and scarce scientific resource, giving the brains of deceased donors a second life as a key driver of life-changing neuropsychiatric research.
Nearly 60 million adults in the U.S. suffer from a psychiatric disorder, and examining the brains of these individuals is indispensable for determining the molecular mechanisms underlying these diseases. Consequently, the HBCC provides invaluable assistance to scientists seeking to improve our understanding and treatment of such conditions. In recognition of World Mental Health Day today, let’s take a glimpse into how the Core is accelerating investigations into the mass of gray and white matter that makes each of us who we are.
This page was last updated on Friday, January 14, 2022
